Nymox Pharmaceutical Corp (NYMX) Insider Trading
- $5,563,866.09
- $4,394,000.00
- May 2, 2022
- James George Robinson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 2, 2022 | Director | 1,151,515 | $1.65 | Buy | $1,899,999.75 | |
April 21, 2021 | Director | 13,000 | $2.08 | Buy | $27,040.00 | |
July 9, 2019 | Director | 7,000 | $1.63 | Buy | $11,410.00 | |
July 5, 2019 | Director | 9,000 | $1.45 | Buy | $13,050.00 | |
July 3, 2019 | Director | 8,000 | $1.54 | Buy | $12,320.00 | |
July 1, 2019 | Director | 9,000 | $1.37 | Buy | $12,330.00 | |
June 27, 2019 | Director | 9,000 | $1.56 | Buy | $14,040.00 | |
June 25, 2019 | Director | 9,000 | $1.73 | Buy | $15,570.00 | |
June 20, 2019 | Director | 9,000 | $1.77 | Buy | $15,930.00 | |
June 18, 2019 | Director | 9,000 | $1.67 | Buy | $15,030.00 | |
June 13, 2019 | Director | 8,000 | $1.42 | Buy | $11,360.00 | |
June 11, 2019 | Director | 9,000 | $1.46 | Buy | $13,140.00 | |
June 5, 2019 | Director | 11,000 | $1.55 | Buy | $17,050.00 | |
June 3, 2019 | Director | 9,000 | $1.62 | Buy | $14,580.00 | |
May 30, 2019 | Director | 8,500 | $1.76 | Buy | $14,960.00 | |
May 28, 2019 | Director | 9,000 | $1.68 | Buy | $15,120.00 | |
May 24, 2019 | Director | 8,000 | $1.59 | Buy | $12,720.00 | |
Dec. 21, 2018 | CFO | 6,000 | $1.35 | Buy | $8,100.00 | |
Dec. 19, 2018 | CFO | 5,000 | $1.54 | Buy | $7,700.00 | |
Dec. 12, 2018 | Director | 6,000 | $1.71 | Buy | $10,260.00 | |
Dec. 10, 2018 | Director | 7,500 | $1.62 | Buy | $12,150.00 | |
Dec. 6, 2018 | Director | 1,400 | $1.74 | Buy | $2,436.00 | |
Dec. 4, 2018 | Director | 7,500 | $1.72 | Buy | $12,900.00 | |
Nov. 29, 2018 | Director | 7,000 | $1.81 | Buy | $12,670.00 | |
Nov. 27, 2018 | Director | 8,000 | $1.71 | Buy | $13,680.00 | |
Nov. 20, 2018 | Director | 6,000 | $1.78 | Buy | $10,680.00 | |
Nov. 16, 2018 | Director | 6,000 | $1.93 | Buy | $11,580.00 | |
Nov. 13, 2018 | Director | 7,000 | $2.00 | Buy | $14,000.00 | |
Nov. 9, 2018 | Director | 13,000 | $2.09 | Buy | $27,170.00 | |
Nov. 7, 2018 | Director | 363 | $2.04 | Buy | $740.52 | |
Nov. 2, 2018 | Director | 7,000 | $1.98 | Buy | $13,860.00 | |
Oct. 31, 2018 | Director | 12,000 | $1.79 | Buy | $21,480.00 | |
Oct. 29, 2018 | CEO | 1,687,600 | $2.50 | Sell | $4,219,000.00 | |
Oct. 28, 2018 | General Counsel | 2,900 | $1.72 | Buy | $4,988.00 | |
Oct. 26, 2018 | CEO | 100,000 | $1.75 | Sell | $175,000.00 | |
Oct. 25, 2018 | Director | 10,000 | $1.62 | Buy | $16,200.00 | |
Oct. 22, 2018 | Director | 8,000 | $1.67 | Buy | $13,360.00 | |
March 26, 2018 | Director | 8,000 | $3.93 | Buy | $31,440.00 | |
March 20, 2018 | Director | 8,000 | $4.02 | Buy | $32,160.00 | |
March 15, 2018 | Director | 8,000 | $3.58 | Buy | $28,640.00 | |
March 9, 2018 | Director | 8,000 | $3.48 | Buy | $27,840.00 | |
Feb. 21, 2018 | Director | 6,000 | $3.23 | Buy | $19,380.00 | |
Feb. 16, 2018 | Director | 7,000 | $3.27 | Buy | $22,890.00 | |
Feb. 12, 2018 | Director | 8,000 | $3.27 | Buy | $26,160.00 | |
Feb. 8, 2018 | Director | 10,000 | $3.37 | Buy | $33,700.00 | |
Feb. 2, 2018 | Director | 5,000 | $3.47 | Buy | $17,350.00 | |
Jan. 18, 2018 | Director | 3,000 | $3.14 | Buy | $9,420.00 | |
Aug. 3, 2017 | Director | 10,000 | $3.73 | Buy | $37,300.00 | |
Aug. 2, 2017 | Director | 5,000 | $3.79 | Buy | $18,950.00 | |
Aug. 1, 2017 | Director | 15,000 | $3.72 | Buy | $55,800.00 |
Insiders are both buying and selling Nymox Pharmaceutical Corp stock.
The insider traders at Nymox Pharmaceutical Corp are: James George Robinson, Erik Danielsen, Paul Averback, and Randall J Lanham
The most active insider trader at Nymox Pharmaceutical Corp is James George Robinson with 78 trades.
Paul Averback has sold the most Nymox Pharmaceutical Corp stock with a total value of $8,613,000.00.
James George Robinson has bought the most Nymox Pharmaceutical Corp stock with a total value of $7,443,077.84.
The most recent insider trade for Nymox Pharmaceutical Corp was on May 2, 2022.
The single biggest insider buy for Nymox Pharmaceutical Corp was from James George Robinson with a total value of $1,899,999.75 on May 2, 2022.
The single biggest insider sell for Nymox Pharmaceutical Corp was from Paul Averback with a total value of $4,219,000.00 on Oct. 29, 2018.